Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scpharmaceuticals Inc.

5.17
+0.09001.77%
Post-market: 5.170.00000.00%16:24 EDT
Volume:395.07K
Turnover:2.03M
Market Cap:272.93M
PE:-2.75
High:5.28
Open:5.01
Low:4.96
Close:5.08
Loading ...
Nov 23, 2022

Major Issues Report

8-K - Current report
Nov 22, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 14, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2022

Major Issues Report

8-K - Current report
Jun 15, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
Apr 12, 2022

Major Issues Report

8-K - Current report
Mar 22, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 22, 2022

Major Issues Report

8-K - Current report
Feb 18, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals